Trichomonas IVDs

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Becton Dickinson Pty Ltd

Classe:

Class 3

Prodotto da:

Becton Dickinson and Company 7 Loveton Circle, Sparks, Maryland, 21152 United States Of America

Area terapeutica:

CT822 - Trichomonas IVDs

Indicazioni terapeutiche:

The BD ProbeTec? Trichomonas vaginalis (TV) Qx Amplified DNA Assay, when tested with the BD Viper? System in Extracted Mode, uses Strand Displacement Amplification technology for the direct, qualitative detection of Trichomonas vaginalis DNA in clinician-collected female endocervical swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and female urine specimens. The assay is indicated for use with asymptomatic and symptomatic females to aid in the diagnosis of trichomoniasis.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2013-12-12